Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | AHR | P35869 | 4/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.40 |
| ▸ | GABRD | O14764 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.40 |
| ▸ | GABRE | P78334 | 2/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24171352 | 0.96 | ALOX5 (0.46) | ALOX5AHRPLA2G2APLA2G4AGABRP | |
| SCHEMBL25762962 | 0.91 | AHR (0.49) | ALOX5AHRPLA2G2APLA2G4AGABRP | |
| SCHEMBL22884595 | 0.91 | AHR (0.51) | ALOX5AHRGABRPGABRDGABRA1 | |
| SCHEMBL29993340 | 0.91 | AHR (0.51) | ALOX5AHRGABRPGABRDGABRA1 | |
| SCHEMBL22136025 | 0.88 | ALOX5 (0.42) | ALOX5AHRGABRPGABRDGABRA1 | |
| SCHEMBL25762939 | 0.87 | GABRP (0.49) | ALOX5AHRGABRPGABRDGABRA1 | |
| SCHEMBL25762991 | 0.86 | ALOX5 (0.45) | ALOX5AHRGABRPGABRDGABRA1 | |
| SCHEMBL17057168 | 0.85 | ALOX5 (0.52) | ALOX5AHRPLA2G2APLA2G4AGABRP | |
| SCHEMBL24352858 | 0.84 | AHR (0.56) | ALOX5AHRCA1CA2TNKS | |
| SCHEMBL25762968 | 0.84 | AHR (0.47) | ALOX5AHRGABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | OR51E2, CYP4F11, OR10J3 | ALOX5 265/4885AHR 42/4885PLA2G2A 3615/4885 |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | OR51E2, CYP4F11, OR10J3 | ALOX5 265/4885AHR 42/4885PLA2G2A 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.